Key result
Lysosomal storage disorders drive diverse cardiac pathologies, notably hypertrophic and dilated cardiomyopathy.
Why the study?
Cardiac disease is a particularly important manifestation in several lysosomal storage disorders, including Anderson-Fabry disease, Pompe disease, Danon disease, and mucopolysaccharidoses.
Answers are grounded in this paper and cite their sources.
Lysosomal storage disorders such as Anderson-Fabry, Pompe, and Danon diseases frequently manifest with significant cardiac pathology including hypertrophic and dilated cardiomyopathy, coronary artery disease, and valvular disease.
ysosomal storage disorders (LSD) comprise a group of more than 40 diseases caused by a deficiency of lysosomal enzymes, membrane transporters or other proteins involved in lysosomal biology.The predominant inheritance pattern is autosomal recessive except for Anderson-Fabry disease, glycogen storage disease (GSD) type IIb (Danon disease) and mucopolysaccharidosis (MPS) type II (Hunter disease).While the metabolic defects affect all cells, clinical organ involvement usually occurs only in the presence of substrate excess or metabolic pathway activation.Cardiac disease is particularly important in lysosomal glycogen storage diseases (Pompe and Danon disease), mucopolysaccharidoses and in glycosphingolipidoses (Anderson-Fabry disease).Various disease manifestations may be observed including hypertrophic and dilated cardiomyopathy, coronary artery disease and valvular disease (table 1).
No takes yet. Share an insight, caveat, or question.
Linhart et al. (2007) conducted a review in Lysosomal storage disorders (including Anderson-Fabry disease, Pompe disease, Danon disease, and mucopolysaccharidoses). Lysosomal storage disorders (>40 diseases), particularly Anderson-Fabry, Pompe, and Danon diseases, cause hypertrophic and dilated cardiomyopathy, coronary artery disease, and valvular disease.
Synapse has enriched 10 related papers. Consider them for comparative context: